BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 917837)

  • 1. [Treatment of Hodgkin's disease stages I, II, and III].
    Teillet F; Bayle-Weisgerber C; Andrieu JM
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):485-94. PubMed ID: 917837
    [No Abstract]   [Full Text] [Related]  

  • 2. [Laparotomy in the therapy of Hodgkin's disease].
    Bauters F; Jouet JP; Caulier MT; Wurtz A; Ribet M; Goudemand M
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):495-502. PubMed ID: 917838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemotherapy-radiotherapy association in the treatment of localized forms of Hodgkin's disease. Prognosis of polychemotherapy after three trials of M.O.P.P].
    Baillet F; Brun B; Mazeron JJ; Rochant H; Pinon G; Reyes F; Vernant JP; Pierquin B; Dreyfus B
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):457-61. PubMed ID: 917834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances and controversies in the management of Hodgkin's disease.
    O'Brien PH; Wallace K; Rambo VB
    Surg Gynecol Obstet; 1975 Mar; 140(3):445-51. PubMed ID: 803722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hodgkin's disease: classification, staging, therapy].
    Wewerka JR
    Schweiz Med Wochenschr; 1978 Aug; 108(32):1241-6. PubMed ID: 150029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenectomy effects on chemotherapy in Hodgkin's disease.
    Panettiere F; Coltman CA
    Arch Intern Med; 1973 Mar; 131(3):362-6. PubMed ID: 4688035
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of Hodgkin's disease. Experience of the Hôpital Saint-Louis].
    Boiron M; Teillet F; Weisgerber C; Dana M; Jacquillat C; Bernard J
    Rev Prat; 1974 Oct; 24(45):3971-8. PubMed ID: 4445767
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease].
    Aghai E; Kende G; Many A; Ramot B
    Harefuah; 1974 Apr; 86(7):348-51. PubMed ID: 4846045
    [No Abstract]   [Full Text] [Related]  

  • 9. [Polychemotherapy of Hodgkin's disease. Long-term results in 226 cases].
    Jacquillat C; Auclerc G; Gemon-Auclerc MF; Weil M; Chastang C; Boiron M; Bernard J
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):473-83. PubMed ID: 917836
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined radiotherapy and chemotherapy in the treatment of Hodgkin's disease.
    Tubiana M; Mathé G
    Ser Haematol; 1973; 6(2):202-43. PubMed ID: 4206180
    [No Abstract]   [Full Text] [Related]  

  • 11. Pediatric Hodgkin's disease.
    Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM
    J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relapses in Hodgkin's disease and their radiochemotherapy (author's transl)].
    Babini L; Sciascia R; Baccarani M; Emiliani E; Fiacchini M; Franchini A; Lauria F; Tura S
    Radiol Med; 1978 Feb; 64(2):113-8. PubMed ID: 684251
    [No Abstract]   [Full Text] [Related]  

  • 13. [Recent progress in the treatment of Hodgkin's disease].
    Jacquillat C
    Acquis Med Recent; 1977; ():89-98. PubMed ID: 910606
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination chemotherapy and survival in advanced Hodgkin's disease.
    Canellos GP; Young RC; Berard CW; DeVita VT
    Arch Intern Med; 1973 Mar; 131(3):388-90. PubMed ID: 4569375
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients].
    Andrieu JM; Casassus P; Coscas Y; Darmont J; Goubeau C; Katz M; Jacquillat C; Tricot G; Weil M
    Bull Cancer; 1982; 69(4):321-9. PubMed ID: 6897520
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal.
    DeVita VT
    Natl Cancer Inst Monogr; 1973 May; 36():373-9. PubMed ID: 4744596
    [No Abstract]   [Full Text] [Related]  

  • 17. Stage I-II Hodgkin's disease: current therapeutic options and recommendations.
    Hoppe RT
    Blood; 1983 Jul; 62(1):32-6. PubMed ID: 6688032
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation and treatment of Hodgkin's disease in the 70's.
    Einhorn LH
    Conn Med; 1975 Nov; 39(11):694-8. PubMed ID: 1102248
    [No Abstract]   [Full Text] [Related]  

  • 19. Current trend in the treatment of Hodgkin's disease.
    Tubiana M; Amiel JL; Hayat M; Henry-Amar M; Cosset JM; Droz JP; Carde P
    Radiat Med; 1983; 1(3):221-9. PubMed ID: 6390537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Status and perspectives in chemotherapy of Hodgkin's disease.
    Frei E
    Arch Intern Med; 1973 Mar; 131(3):439-45. PubMed ID: 4739436
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.